GRANT Life Sciences, Inc. Product Pipeline Analysis

SUMMARY

GRANT Life Sciences, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a GRANT Life Sciences, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
2.3 Industry Outlook -- In Vitro Diagnostics 8
3 Business Description 9
3.1 Business Overview 9
3.2 Major Products and Services 9
3.2.1 Overview 9
4 History 10
5 Competitors 11
6 Key Employees 12
7 Key Employee Biographies 13
8 Company Statement 15
9 Locations And Subsidiaries 16
9.1 Head Office 16
9.2 Other Locations & Subsidiaries 16
10 Recent Developments 17
10.1 Strategy And Business Planning 17
10.1.1 Oct 27, 2006: Grant To Explore Expanded Partnership With DTL 17
10.2 Corporate Communications 17
10.2.1 Mar 26, 2007: Grant Life CFO Retires, Appoints New CFO 17
10.3 Legal and Regulatory 17
10.3.1 Jan 16, 2007: Grant Signs MOU With UCl 17
10.3.2 Apr 12, 2006: Grant Enters MoU With DTL 18
10.4 Product News 19
10.4.1 Jan 22, 2008: Chinese And U.S. patents Issue To Grant Life Sciences For Its Blood Test That Detects Cervical Cancer 19
10.4.2 Nov 13, 2007: Grant Life Sciences In-licenses HPV DNA-based Test From Alphagenics 19
10.4.3 Nov 13, 2007: Grant Life Sciences In-Licenses HPV DNA-based Test From Alphagenics 19
10.4.4 Apr 12, 2006: Grant Life Sciences ('Grant') Enters Into a Memorandum of Understanding with Diagnostic Technologies Ltd. ('DTL') to Develop and Commercialize Grant's Cervical Cancer-Diagnostic Technology. 20
11 GRANT Life Sciences, Inc. Pipeline Products 21
11.1 GRANT Life Sciences, Inc. Product Pipeline Analysis 21
11.1.1 GRANT Life Sciences, Inc. Pipeline Products By Equipment Type 21
11.1.2 GRANT Life Sciences, Inc. Pipeline Products By Development Stage 23
11.1.3 GRANT Life Sciences, Inc. Pipeline Products By Therapy Area 23
11.1.4 GRANT Life Sciences, Inc. Pipeline Products By News Summary 24
11.2 Cervical Diagnostic 24
11.2.1 Product Description 25
11.2.2 Product Status 25
11.2.3 Product Milestone 25
11.3 HPV DNA-based Test 26
11.3.1 Product Description 26
11.3.2 Product Status 26
11.3.3 Product Milestone 26
11.4 Serum-based test for detecting Cervical Cancer 27
11.4.1 Product Description 27
11.4.2 Product Status 27
11.4.3 Product Milestone 27
11.4.4 Product Patent Details 28
12 Appendix 29
12.1 Methodology 29
12.1.1 Coverage 29
12.1.2 Secondary Research 30
12.1.3 Primary Research 30
12.1.4 Expert Panel Validation 31
12.2 Contact Us 31
12.3 About Global Markets Direct 31
12.4 Disclaimer 31

1.1 List of Tables
Table 1: GRANT Life Sciences, Inc.,Key Facts 8
Table 2: GRANT Life Sciences, Inc., Key Employees, 12
Table 3: GRANT Life Sciences, Inc., Other Locations 16
Table 4: GRANT Life Sciences, Inc. Pipeline Products by Equipment Type 22
Table 5: GRANT Life Sciences, Inc. Pipeline Products By Development Stage 23
Table 6: GRANT Life Sciences, Inc. Pipeline Products By Therapy Area 23
Table 7: GRANT Life Sciences, Inc. Pipeline Products By News Summaries 24

1.2 List of Figures
Figure 1: GRANT Life Sciences, Inc. Pipeline Products By Equipment Type 21
Figure 2: GRANT Life Sciences, Inc. Pipeline Products By Equipment Type 22
Figure 3: GRANT Life Sciences, Inc. Pipeline Products By Development Stage 23
Figure 4: GRANT Life Sciences, Inc. Pipeline Products By News Summary 24
Figure 5: Global Markets Direct Methodology 29